Over the last 2 decades, the threshold of standard infrarenal abdominal aortic aneurysm (AAA) repair remains firm at 5.5 cm for male patients. 1, 2 Even in the most recent guidelines of the Society for Vascular Surgery and the European Society for Vascular Surgery, it is recommended that male patients with an asymptomatic fusiform AAA 55 mm should be considered for repair, while for the smaller ones, surveillance is recommended. 1, 2 This cutoff value was determined mainly by 2 randomized control trials (RCTs) where the risk of rupture exceeded operative risks from open surgical repair (OSR) and therefore elective surgery would not be justified at 4 to 5.5 cm. 3, 4 However, in the design of United Kingdom Small Aneurysm Trial (UKSAT), 5 it is mentioned that by that time for most physicians there was a grey area of uncertainty concerning the best management of aneurysms between 4 and 6 cm in diameter. After vigorous discussion at the Vascular Surgical Society of Great Britain and Ireland, a group of surgeons agreed upon their grey area of uncertainty: asymptomatic aneurysms of 4.0 to 5.5 cm in diameter in fit patients aged 60 to 76 years. The question still exists: What would have happened if those surgeons had agreed on a grey zone of 4 to 5 cm?
The UKSAT was based on ultrasonographic measurements of the aneurysm including anteroposterior maximum diameter, while the Aneurysm Detection and Management study used only axial computed tomography angiography (CTA) measurements. In the UKSAT, 70% of the patients had CTA scans revealing diameters of >5.5 cm in patients who had demonstrated an underestimated diameter of 5 to 5.4 cm in the ultrasound. 6 Currently, there is no common consensus regarding a standardized methodology for AAA maximum diameter measurement. 7 For example, maximum diameters measured in the same patient according to methods used in the literature might range from 49.8 to 56.8 mm using ultrasound and 52 to 60.2 mm using CTA. 7 Another important issue regarding the UKSAT was that the elective operative mortality rate was higher than expected (5.8%), while more than half of the initially screened patients (61%) in the surveillance group underwent AAA repair during the follow-up period because of AAA expansion or symptoms. 8 After the introduction of endovascular aortic aneurysm repair (EVAR) in the treatment of patients with AAA, 2 more recent RCTs were undertaken investigating whether there are survival advantages from EVAR in patients with small AAAs (<5.5 cm): the Comparison of Surveillance versus Aortic Endografting for Small Aneurysm Repair (CAESAR) Trial 9 and the Positive Impact of endoVascular Options for Treating Aneurysms earLy investigators (PIVOTAL) trial. 10 These studies suggested that mortality and rupture rates in small AAAs are low and no clear advantage could be demonstrated between early and delayed EVAR strategy. However, it is of note that these 2 studies examined different populations. The PIVOTAL study included AAAs in the range of 4.0 to 5.0 cm, while the CAESAR study recruited patients with AAA measuring 4.1 to 5.4 cm. Therefore, a subpopulation of patients with AAAs of maximum diameter between 5.1 and 5.4 cm were included in the CAESAR, but not in the PIVOTAL study. That could explain the surprisingly low rupture rate (0.3%) in the PIVO-TAL study and the higher rate of subsequent AAA repairs in the surveillance group in the CAESAR study (60% vs 31%). It would be interesting if the CAESAR study could have provided a subgroup analysis of those with 5.0 to 5.4 cm. Recently, in the Vascular Study Group of New England, patients who had undergone EVAR for small AAAs represented more than a third of elective cases. 11 They demonstrated that EVAR for large diameter AAAs was associated with higher comorbidity burden and diminished long-term survival. 11 Along these lines, a previous systematic review of the literature, which was performed to identify studies comparing the outcomes of EVAR between large (>5.5 cm) and small aneurysms, including 7735 patients, demonstrated that EVAR in small AAAs might be associated with lower operative and aneurysm-related mortality and aneurysm rupture incidence. 12 A collaboration of 11 vascular surgical quality registries by the International Consortium of Vascular Registries has demonstrated that among 51 153 patients, with intact AAA, 31% of male and 12% of female patients were treated at smaller diameter than guidelines recommended. In countries that physicians treated more small AAAs, there was a tendency to use EVAR over OSR. 13 Interestingly, in the same collaboration, after further analysis of 9273 patients who were treated for AAA rupture, 10.7% of those had a small AAA (<5.5 cm in diameter). 14 Additionally, Karthikesalingam et al 15 found that the rate of AAA repair is generally higher in the United States compared with England and particularly for smaller diameter AAAs (<5.5 cm). In this study, the rupture and aneurysmrelated death rates were lower in the United States than in England.
While it appears that a consensus exists to intervene when AAA exceeds 5.4 cm, it is of interest that even the current guidelines recognize that there are some cases (female gender, chemotherapy or radiation therapy, solid organ transplantation, smoking, hypertension, chronic airway disease, saccular morphology) in which intervention is recommended at a diameter of 5.0 cm because of a higher risk of rupture. 1, 2 Nevertheless, the argument against the concept of the use of AAA diameter as an absolute criterion to intervene is still valid in the presence of the substantial evidence accumulated over the last years. Iliac tortuosity and cross-sectional AAA diameter asymmetry have been previously associated with higher incidence of rupture. 16 Also, increased intraluminal thrombus has been associated with higher incidence of aneurysm rupture at smaller diameters. 17 Recently, Barrett et al 18 highlighted that the use of additional biomechanical-structural characteristics of AAA may be a helpful adjunct to improve the accuracy of AAA rupture prediction. Ghulam et al 19 demonstrated that in a cohort of small AAAs, 40% of patients with a stable diameter had an increasing aortic volume at 12-month follow-up.
In conclusion, all this evidence implies that not all small AAAs (<5.5 cm in diameter) should be disqualified from intervention. Abdominal aortic aneurysm diameter might not be the only indicator to identify the risk for rupture. A more robust case selection is needed, as in some of them when the AAA diameter reaches 5.0 cm, the risk for rupture may be substantially increased. Guidelines 1,2 recommend intervention for saccular aneurysms at a lower aneurysm diameter threshold and in patients with a small aneurysm who will require chemotherapy, radiation therapy, or solid organ transplantation. In contrast, their recommendations 1,2 for AAAs with a diameter <5.5 cm were based on relatively old studies. 3, 4, 9, 10 Therefore, it is reasonable to propose that further research is needed to settle the issue. There is also a need to establish whether there are realistic options (eg, statin use) to slow down the expansion of AAAs. 20 
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